Collegium Pharmaceutical Releases Positive Top-Line Results of Oral Human Abuse Potential (HAP) Study with Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Product by longitudeadmin | Nov 17, 2014 | Portfolio News
Collegium: Emerging Player in Abuse-Deterrent Opioids by longitudeadmin | Nov 3, 2014 | Portfolio News
Practice Fusion Launches Brand New Electronic Health Records (EHR) Platform, Optimized for Apple iPad™, iPad mini™ and Android™ Tablets by longitudeadmin | Oct 27, 2014 | Portfolio News
Esperion Therapeutics Announces Closing of Follow-On Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock by longitudeadmin | Oct 21, 2014 | Portfolio News
Esperion Therapeutics Announces Positive Top-Line Phase 2b Results for ETC-1002, An Investigational Therapy for Patients with Hypercholesterolemia by longitudeadmin | Oct 1, 2014 | Portfolio News
